Ignite Creation Date:
2024-05-05 @ 11:00 PM
Last Modification Date:
2024-10-26 @ 10:27 AM
Study NCT ID:
NCT01231594
Status:
COMPLETED
Last Update Posted:
2019-03-22
First Post:
2010-10-21
Brief Title:
A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumors
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis